Vladimı́r Vonka

1.1k total citations
58 papers, 920 citations indexed

About

Vladimı́r Vonka is a scholar working on Epidemiology, Genetics and Immunology. According to data from OpenAlex, Vladimı́r Vonka has authored 58 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 19 papers in Genetics and 17 papers in Immunology. Recurrent topics in Vladimı́r Vonka's work include Virus-based gene therapy research (18 papers), Herpesvirus Infections and Treatments (18 papers) and Cytomegalovirus and herpesvirus research (13 papers). Vladimı́r Vonka is often cited by papers focused on Virus-based gene therapy research (18 papers), Herpesvirus Infections and Treatments (18 papers) and Cytomegalovirus and herpesvirus research (13 papers). Vladimı́r Vonka collaborates with scholars based in Czechia, United States and Serbia. Vladimı́r Vonka's co-authors include Matilda Benyésh-Melnick, Michal Šmahel, Viera Ludvı́ková, Ivan Hirsch, Eva Hamšíková, L Kutinová, Robert M. McCombs, Iuri Marinov, Z Roth and Priscilla A. Schaffer and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Vladimı́r Vonka

57 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vladimı́r Vonka Czechia 19 552 297 247 198 175 58 920
C A Heilman United States 16 529 1.0× 246 0.8× 355 1.4× 386 1.9× 247 1.4× 24 1.3k
Martine Y. K. Armstrong United States 17 565 1.0× 430 1.4× 175 0.7× 200 1.0× 111 0.6× 27 1.2k
Phillip K. Weck United States 13 319 0.6× 297 1.0× 144 0.6× 162 0.8× 145 0.8× 30 769
Y Chardonnet France 16 492 0.9× 171 0.6× 187 0.8× 172 0.9× 156 0.9× 93 808
V. Vonka Czechia 20 859 1.6× 403 1.4× 360 1.5× 264 1.3× 257 1.5× 120 1.4k
Alessandro Ripalti Italy 23 760 1.4× 98 0.3× 209 0.8× 262 1.3× 135 0.8× 50 1.1k
Kirsten Freitag Germany 19 581 1.1× 718 2.4× 171 0.7× 225 1.1× 112 0.6× 34 1.1k
Lesley Pesnicak United States 24 927 1.7× 444 1.5× 172 0.7× 147 0.7× 201 1.1× 38 1.4k
Nina Wedderburn United Kingdom 18 239 0.4× 365 1.2× 276 1.1× 88 0.4× 132 0.8× 55 931
M. Scriba Austria 15 664 1.2× 317 1.1× 552 2.2× 158 0.8× 124 0.7× 29 1.3k

Countries citing papers authored by Vladimı́r Vonka

Since Specialization
Citations

This map shows the geographic impact of Vladimı́r Vonka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimı́r Vonka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimı́r Vonka more than expected).

Fields of papers citing papers by Vladimı́r Vonka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimı́r Vonka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimı́r Vonka. The network helps show where Vladimı́r Vonka may publish in the future.

Co-authorship network of co-authors of Vladimı́r Vonka

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimı́r Vonka. A scholar is included among the top collaborators of Vladimı́r Vonka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimı́r Vonka. Vladimı́r Vonka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vonka, Vladimı́r & Ivan Hirsch. (2021). Prophylactic vaccines against cancers of non-infectious origin: a dream or a real possibility?. Central European Journal of Public Health. 29(4). 247–258. 2 indexed citations
2.
Hamšíková, Eva, et al.. (2017). Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients. Acta Haematologica. 137(3). 148–157. 3 indexed citations
3.
Vonka, Vladimı́r, et al.. (2015). Kynurenine and uric acid levels in chronic myeloid leukemia patients. OncoImmunology. 4(3). e992646–e992646. 17 indexed citations
4.
Vonka, Vladimı́r, et al.. (2015). Immunology of chronic myeloid leukemia: current concepts and future goals. Expert Review of Clinical Immunology. 11(4). 511–522. 10 indexed citations
5.
Vonka, Vladimı́r. (2010). Immunotherapy of Chronic Myeloid Leukemia: Present State and Future Prospects. Immunotherapy. 2(2). 227–241. 11 indexed citations
6.
Klamová, Hana, I Janatková, Karin Malíčková, et al.. (2010). Changes of Immunological Profiles in Patients with Chronic Myeloid Leukemia in the Course of Treatment. Journal of Immunology Research. 2010(1). 137320–137320. 11 indexed citations
7.
Smetana, Karel, Barbora Dvořánková, Lukáš Lacina, Zdeněk Čada, & Vladimı́r Vonka. (2008). Human hair follicle and interfollicular keratinocyte reactivity to mouse HPV16-transformed cells: An in vitro study. Oncology Reports. 20(1). 75–80. 6 indexed citations
8.
9.
Šmahel, Michal, et al.. (2004). Chemotherapy and immunotherapy of tumours induced by gene-modified HPV16-transformed cells. Oncology Reports. 12(4). 877–83. 5 indexed citations
10.
11.
Němečková, Šárka, L Kutinová, Pavel Otáhal, et al.. (2002). Immune response to E7 protein of human papillomavirus type 16 anchored on the cell surface. Cancer Immunology Immunotherapy. 51(2). 111–119. 11 indexed citations
12.
Indrová, M, Luis Mendoza, Milan Reiniš, et al.. (2001). Bone marrow dendritic cell-based anticancer vaccines. Advances in experimental medicine and biology. 495. 355–358. 2 indexed citations
13.
Šmahel, Michal, et al.. (2001). Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells. Virology. 281(2). 231–238. 91 indexed citations
14.
Sanjosé, Sílvia de, Eva Hamšíková, Nubia Muñóz, et al.. (1996). Serological response to HPV16 in CIN‐III and cervical‐cancer patients. Case‐control studies in Spain and Colombia. International Journal of Cancer. 66(1). 70–74. 2 indexed citations
15.
Sanjosé, Sílvia de, Eva Hamšíková, Nubia Muñóz, et al.. (1996). Serological response to HPV16 in CIN-III and cervical-cancer patients. Case-control studies in Spain and Colombia. International Journal of Cancer. 66(1). 70–74. 26 indexed citations
16.
17.
Liška, Vladimír, Jan E. Dyr, Jiřı́ Suttnar, Ivan Hirsch, & Vladimı́r Vonka. (1994). Production and simple purification of a protein encoded by part of the gag gene of HIV-1 in the Escherichia coli HB101F+ expression system inducible by lactose and isopropyl-β-d-thiogalactopyranoside. Journal of Chromatography B Biomedical Sciences and Applications. 656(1). 127–133. 4 indexed citations
18.
Votruba, Ivan, et al.. (1990). Phosphonylmethyl ethers of acyclic nucleoside analogues: Inhibitors of HSV-1 induced ribonucleotide reductase. Antiviral Research. 13(5). 253–263. 26 indexed citations
19.
Hirsch, Ivan, et al.. (1976). Replicating DNA of Herpes Simplex Virus Type 1. Intervirology. 7(3). 155–175. 18 indexed citations
20.
Benyésh-Melnick, Matilda, et al.. (1966). Human Cytomegalovirus: Properties of the Complement-Fixing Antigen. The Journal of Immunology. 96(2). 261–267. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C A Heilman Breakdown of academic impact, for papers by Martine Y. K. Armstrong Breakdown of academic impact, for papers by Phillip K. Weck Breakdown of academic impact, for papers by Y Chardonnet Breakdown of academic impact, for papers by V. Vonka Breakdown of academic impact, for papers by Alessandro Ripalti Breakdown of academic impact, for papers by Kirsten Freitag Breakdown of academic impact, for papers by Lesley Pesnicak Breakdown of academic impact, for papers by Nina Wedderburn Breakdown of academic impact, for papers by M. Scriba
Rankless by CCL
2026